NCT01865318 Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01865305 Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes Status COMPLETED Phase PHASE1
NCT01865292 Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01865279 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec Status COMPLETED Phase PHASE1
NCT01864460 Improving Autonomic Function and Balance in Diabetic Neuropathy Status COMPLETED Phase NA
NCT01861860 OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA Status COMPLETED Phase NA
NCT01859793 Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy Status COMPLETED Phase PHASE4
NCT01859598 Observational Registry for Basal Insulin Treatment Study (ORBIT) Status COMPLETED Phase N/A
NCT01859494 Evaluation of an Investigational Blood Glucose Monitoring System Status COMPLETED Phase NA
NCT01857375 A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe Status COMPLETED Phase N/A
NCT01855399 Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes Status COMPLETED Phase NA
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Status COMPLETED Phase NA
NCT01850615 Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Status WITHDRAWN Phase NA
NCT01849289 A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01846312 An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes Status COMPLETED Phase N/A